ASTELLAS PHARMA UNSP/ADR (ALPMY) earnings
Quarterly and annual ALPMY reports and results, each read against the price at its own news timestamp. Back to the ALPMY overview →
No ALPMY earnings events in the measured window.
Nothing matched in the current window — the ALPMY overview has every event we measure for this name.
Get an email when ALPMY moves on news →Keep exploring
More ALPMY: analyst actions → · SEC filings → · ALPMY overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Utah Medical Products, Inc. (UTMD) | 96 | 0.00% | 48% |
| Pieris Pharmaceuticals, Inc. (PIRS) | 95 | 0.00% | 39% |
| Check-Cap Ltd. - Ordinary Share (CHEK) | 94 | -0.11% | 42% |
| Titan Pharmaceuticals, Inc. (TTNP) | 94 | +0.47% | 61% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.